An automated system for polymerase chain reaction (PCR) amplification and detection combats false-positive results caused by "PCR product carryover." The system uses a singlevesselfor both PCR amplification and the subsequent detection of PCR products,eliminatingthe need to handle PCR products in an open environmentand riskproductcarryover. The sample and PCR reagents are introduced into one compartment within the vessel, and amplification occurs as they are thermally cycled. Other compartments contain the reagents for detection of PCR products. Pressure from a roller provides for sequential delivery of the contents of the compartments to a detection area The PCR products are biotinylated at their 5' ends during amplification through the use of biotinylated primers. After delivery to the detection area, they are specifically captured by hybridization with immobilized oligonucleotideprobes. Subsequent reactionwith streptavidin-horseradish peroxidase conjugate formsa complexthat catalyzes dye formationfroma dye precursor. Wash steps minimize nonspecific background. This format is amenable to multiplexing, permitting internal controls, speciation of bacteria, typing of viruses, and paneltesting. An HIV assay performed with this system demonstrated 100% sensitivity and 95% specificity for 64 patients' samples relative to a conventional PCR assay based on 32P solution hybridization.
Design Goals
False-positive results from "product carryover" have long been a major concern for practitioners of PCR (2, 3). These false-positive results are caused by infinitesimal amounts of previously amplified PCR products contaminating equipment, clothing, or personnel and being inadvertently transferred into subsequent PCR reactions and reamplified.
Without a solution to this problem, PCRbased assays cannot be clinically useful.
It is also important that the PCR process be robust in an assay system. The efficiency and sensitivity of the desired amplification process must be maximized while nonspecific amplification is minimized. Avoiding nonspecific primer extensions before the first thermal cycle is a key means of improving amplification efficiency (4). The term "hot starts" has been coined to describe methods that prevent primer extensions before the PCR reagents attain a temperature that ensures adequate stringency.
Two of the most common technologies used for detecting and confirming PCR products are electrophoresis and the use of radiolabels.
Long the workhorse detection methods in research laboratories, they are impractical for routine use in clinical laboratories.
They are far too time-consuming and labor-intensive and would burden an already overworked laboratory staff. Development of a PCR product detection technology to replace these methods is therefore another design goal.
Ideally, assays in routine use in clinical laboratories should be simple, easy to use, rapid, and as highly automated as the technology permits, while providing accurate results with high sensitivity and specificity. Such assays free laboratory personnel to devote time to other critical laboratory activities and reduce the level of training required. In addition, rapid delivery of diagnostic results to the physician allows these results to affect patient treatment. Assay accuracy can be improved through including internal positive and negative controls to guard against false-negative and false-positive results. Therefore, our design objectives were to develop a PCR- based assay system that controls the product carryover problem, is robust, and obviates electrophoresis and radiolabels as detection methods. Moreover, automation of the amplification and detectionprocesses was a goal with a longer-term objective of expanding automation to include sample preparation. The overall system should be simple and rapid but also demonstrate good sensitivity and specificity. Internal positive and negative controls were recognized as a viable means of improving assay performance. A system that met these design objectives would take a major step towards making PCR a practical reality in clinical laboratories.
Controlling product carryover. After amplification, a PCRreactionmixmaycontainasmanyas6
x 10"copies of the original target.
Given the desirability that PCRbased assays for infectious pathogens be sensitive to <60 copies of the target sequence, this means that 108 L (roughly, a billionth of a drop) of the postamplification mix contains sufficient target to contaminate a subsequent amplification process and cause a false-positive result. Methods of avoiding such carryover contamination, or of rendering it harmless, are a tough but necessary challenge. False positivesfrom product carryover have plagued PCR assays for many years, and several possible solutions to this problem have been proposed and developed, e.g., observation of strict protocols, enzymatic or chemical treatment of PCR products to render them unampliuiable, and limiting the level of amplification. Among the strict protocols routinely followed by most laboratories attempt- 
Materials and Methods

Nonisotopic Detection Format
The reaction scheme used for detecting the PCR products (Figure 1) This reaction scheme allows for detection of multiple sequences simultaneously, because the capture reaction is specific and the signal generation reagents are generic. Multiple populations of latex partides, containing different oligonucleotide probes, can be immobilized at discrete locations on a surface (Figure 3) . The surface can then be exposed to a PCR reaction mix containing one or more PCR products for the hybridization reaction under controlled stringency conditions. After the time allotted for hybridization (-5 mm), biotinylated PCR products will be captured on discrete spots wherever they encounter probes complementary to their sequence. should not hybridize to any of the sample or positivecontrol PCR products. It provides a measure of nonspecific background, against which the sample and positive control signals can be compared.
Prototype ofDisposableContainmentVessel
The prototype containment vessel, called a PCR "pouch" (Figure 5 ), has compartments for PCR amplification, detection of PCR products, and storage of the required detection reagents. it is manufactured from two sheets of heatsealable plastic (laminated packaging film consisting of 0.089-mm-thick linear low-density polyethylene and 0.013-mm-thick polyethylene terephthalate); channels and compartments are formed in a thermal setting process. In the detection area, the oligunudeotide probes, covalently attached to latex particles, are immobilized at discrete locations on the polyethylene side of the laminate. The detection fluids (streptavidin-horseradish peroxidase conjugate, wash solution, and dye precursor solution) are dispensed into their respective compartments before the two plastic sheets are heat-sealed together with the polyethylene sides on the inside of the vessel. The PCR reagent mix (PCR reagents and prepared sample) is loaded by the operator into the PCR compartment through a fill port just before beginning the assay.
PCR products and the detection reagents are delivered from their compartments to the detection area through the channels, and the signal is generated in this area. The dye development is monitored visually by comparison against a color density chart; however, the system is compatible with an automated instrtunent measurement by reflection densitometry.
A roller mechanism provides pressure on each compartment sequentially, rupturing the seal of the compartment and causing the fluid to flow into the channel. The programmed motion of the roller permits delays for reactions to take place in the detection area.
Prototype PCR Amplification and Detection Processor
The instrument process. Forced air is used for the cooling parts of the cycles and is dispensed through vents in the heaters. Another heater mounted in the top plate of the instrument controls the temperature in the detection area, so that the hybridization, conjugate-binding, wash, and dye development reactions take place under controlled conditions. The top PCR heater advances with the roller and can be used to heat fluids in the other compartments as needed. The heaters and the roller motion are all computer controlled. Table 1 shows typical conditions for pouch processing.
The processor and the PCR pouch allow for extremely efficient thermal transfer during the PCR process. The PCR compartment is sandwiched between two heater/coolers and is thus accessed from both sides. In addition, the fluid in the compartment is compressed into the shape of a thin disk, minimizing the heat transfer distance. The compliant nature of the material that forms the compartment causes it to conform to the surface of the heaters, which minimizes the presence of detrimental air gaps. Moreover, the walls of the compartment are thin (0.102 nun). Together, these features permit extremely rapid thermal cycling, as shown in Figure 7 . This capability has been used to demonstrate successful
PCR amplification
at cycle times of -22 s, as judged by the signals obtained relative to the color comparison chart (Table 2 ). However, we routinely use cycle times of -1 mm in our assays.
"Triggering" PCR Amplification to Improve Efficiency
The specificity and sensitivity of PCR amplification can be compromised by nonspecific primer extensions that cccur while the reagents are being assembled.
To combat this process, we use a technique in which key reaction components are withheld from the reaction until sufficiently high temperature has been achieved. We developed an automated method of performing this technique, in which monoclonal antibodies bind to and inhibit Taq polymerase during reagent assembly. These antibodies are denatured before the PCR amplification by exposure to high temperatures, and the PCR process can begin under stringent conditions (Figure 8 ). The use of this triggering technology has been shown to result in a much more specific amplification, minimizing the number of nonspecific bands visible on agarose gels stained with ethidium bromide. In addition, triggering permits detection of target 
Results
Application
of the contained, automated system to infectious disease assays. To determine whether the contained system could be applied to a broad range of infectious disease assays, we first tested the analytical sensitivity of the system by using a model system. The results (data not shown) indicated that the system was capable of detecting only a few molecules of target; this led us to an effort to develop specific assays for human immunodeficiency virus (11W) and cytomegalovirus (CMV).
Each of these assays was developed by using two sets of primers to produce and detect two distinct PCR products. The H1V assay coamplifled sequences from the gag and env regions of the virus and used the antibody triggering described above. The CMV assay coamplifled sequences from the late antigen and major immediate early regions of the virus. These assays, performed under conditions detailed in Table 3 , were compared with PCR assays based on 32P-labeled probes (9, 10). Sample preparation for each assay involved standard phenol/chloroform extraction and ethanol precipitation of purified DNA.
As shown in Table 4 , the results obtained with the contained., automated system compared favorably with those obtained by using the more complex and time-consuming radiolabeled comparison methods. For the HW assay comparison, only one discordant result was obtained from 65 patients' samples (positive by the automated assay). The CMV assay comparison also yielded a single discordant result (negative by the automated assay). In addition, the sensitivity of the automated assays was comparable with that observed for the comparison procedures, as shown with serial dilutions of known standards (Table  5 ). For the HIV assay, dilutions were prepared from HUT! AAV 78 DNA (cell line with one copy of HIV-1 proviral DNA per cell). The phenol/chloroform-purified DNA was quantified by spectrophotometry at 260 nm. For the CMV assay, serial dilutions of CMV 178 genomic DNA (purified detection processes are robust.
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The automated, contained system addresses all of these needs and appears to be a promising alternative.
AmplifiOne additional samplewas indeterminate by the containment assay.
cationand detection take place within an enclosedvessel, eliminating the risks associated with transfer of material from sucrose-isolated virions) were used. Both assays from a PCR vessel to a detection vessel. The use of monocould detect as few as 5 or 10 copies of target, similar to the clonal antibody triggering of the PCR amplification procomparison assays. These results confirmed the feasibility cess improves the specificity, sensitivity, and robustness of of this system for routine assay development.
PCR. Incorporation of internal positive and negative conRefinement of the system. The success of the feasibility experiments has led to development of a more refined system. The pouch shown in Figure 9 has been reduced in size, and a compartment that is no longer needed has been eliminated.
In addition, the detection area has been relocated across the end of the pouch to facilitate instrument reading. Similarly, the prototype processor has been redesigned ( Figure  10 ): This instrument stifi accommodates eight pouches at one time, but they are arranged in one row of eight. The pouches are positioned such that all the detection spots are aligned in a single row. The pouch design can accommodate seven spots or fewer as needed. A scanning mechanism traverses across all eight pouches and determines the reflection density on all spots it encounters.
The overall amplification and detection assay time has been reduced to about 1 h. Typically, 40 cycles of PCR are run with a thermal proffle consisting of 15 s at 95#{176}C and 30 s at 68#{176}C (with ramps, this requires --65 s/cycle). The detection processing requires -15 mm to perform. After the pouches are loaded on the instrument, the system is designed to be completely operator independent, and the results are output on paper tape. The system is designed for batch operation; however, assays that can use the same thermal conditions and detection conditions can be run as mixed batches.
Discussion
Successful use of PCR-based assays in the routine clinical laboratory will demand technological improvements CMV assay formats.
Further refinement of the system is stifi required. These studies demonstrated the feasibility of this approach and have encouraged us to continue development of the system. The ability to multiplex may also prove useful for typing viruses, speciating bacteria, or developing tests for multiple pathogens.
In genetic testing, it could be used to investigate multiple alleles or multiple loci. For certain infectious disease assays, it may be useful to coamplifr and codetect multiple regions of the pathogen to increase assay sensitivity and specificity. The possibility of including standards to render assays more quantitative is also under consideration.
Large clinical studies will ultimately provide the information that allows us to determine how 
